Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00891969

Enrollment

Registered

2009-05-01

Start date

2009-02-28

Completion date

2013-03-31

Last updated

2015-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

stage I breast cancer, stage II breast cancer, stage IIIA breast cancer

Brief summary

RATIONALE: A study that looks at communication between patients and doctors may help oncologists improve patient satisfaction with their treatment plan. PURPOSE: This phase I trial is studying treatment decision making between oncologists and women with newly diagnosed breast cancer and their healthy companions.

Detailed description

OBJECTIVES: Primary * To determine the association between women's and physicians' participatory communication behaviors (e.g., patients asking questions, physicians soliciting questions) on treatment decision-making process and health outcomes. Secondary * To capture the language used in the treatment-decision interactions. * To assess the degree of variation in the language used among physicians and patients who are active participants and those who are less inclined to participate in the treatment decision-making interaction. OUTLINE: Patients and their companions undergo consultation with the physician for treatment decision making. The treatment discussion is audio/videotaped for approximately 45 minutes. Patients complete one short survey prior to physician consultation. After the treatment discussion, patients complete two short surveys, one immediately after the visit in the waiting room before leaving for the day, and the second one a week after the visit by a web-based survey or by mail. PROJECTED ACCRUAL: A total of 300 women with breast cancer and 600 companions of these women will be accrued for this study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

DISEASE CHARACTERISTICS: * Meets one of the following criteria: * Woman with newly diagnosed early-stage breast cancer * Caregiver or companion willing to participate in study PATIENT CHARACTERISTICS: * Speaks native English or has learned to speak English fluently * Patient's companion ≥ 18 years old (if applicable) * Able to complete questionnaires without assistance * Not pregnant PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

Measure	Time frame
The association between patients' and physicians' participatory communication and psychosocial outcomes.	Pre- and post-Initial treatment decision making visit

Countries

United States

Outcome results